Muhealdeen Dana N, Shwan Alan, Yaqo Rafil T, Hassan Hemin A, Muhammed Bryar O, Ali Rawa M, Hughson Michael D
Sulaimani University College of Medicine, Sulaymaniyah, Iraq.
Hiwa Cancer Hospital, Sulaymaniyah, Iraq.
Infect Agent Cancer. 2022 Jul 27;17(1):39. doi: 10.1186/s13027-022-00452-0.
Burkitt's lymphoma (BL) has worldwide variations in incidence that are related to the age of Epstein-Barr virus (EBV) infection. This study examined the age-specific incidence rate (ASIR) of BL and community EBV seropositivity in Iraqi Kurdistan and compared results with data from countries tabulated in the International Incidence of Childhood Cancer volume 3 (IICC-3).
The ASIR (95% confidence intervals) of BL in Sulaimani Governorate of Iraqi Kurdistan were calculated for the years 2010-2020. Specimens from 515 outpatients were tested for IgG and IgM antibodies to EBV viral capsid antigen.
In Sulaimani, 84% of BL occurred under 20 years of age, with an ASIR of 6.2 (4.7-7.7) per million children. This ASIR was not significantly different than that of Egypt, Morocco, Israel, Spain, or France. It was slightly higher than the ASIR of the United States, the United Kingdom, and Germany and markedly higher than for Asia and South Africa. In Africa and much of Asia, early childhood EBV exposure predominates, with nearly all children being infected by 5 years of age. In Sulaimani, just over 50% of children were EBV seropositive at 3 years old and 90% seropositivity was reached at 15 years of age. In Europe and North America, seropositivity is commonly delayed until adolescence or young adulthood and adult predominates over childhood BL.
In the Middle East, childhood BL is relatively common and adult BL is rare. In Sulaimani, EBV seropositivity increases progressively throughout childhood and reaches 92% at mid-adolescence. This may reflect the Mid East more widely. We suggest that the high childhood and low adult BL rates may be a regional effect of a pattern of EBV exposure intermediate between early childhood and adolescent and young adult infections.
伯基特淋巴瘤(BL)在全球的发病率存在差异,这与爱泼斯坦-巴尔病毒(EBV)感染的年龄有关。本研究调查了伊拉克库尔德斯坦地区BL的年龄别发病率(ASIR)以及社区EBV血清阳性率,并将结果与《国际儿童癌症发病率第3卷》(IICC-3)中列出国家的数据进行比较。
计算了2010 - 2020年伊拉克库尔德斯坦苏莱曼尼亚省BL的ASIR(95%置信区间)。对515名门诊患者的样本进行了EBV病毒衣壳抗原IgG和IgM抗体检测。
在苏莱曼尼亚,84%的BL发生在20岁以下,每百万儿童的ASIR为6.2(4.7 - 7.7)。该ASIR与埃及、摩洛哥、以色列、西班牙或法国的ASIR无显著差异。略高于美国、英国和德国的ASIR,明显高于亚洲和南非。在非洲和亚洲大部分地区,幼儿期EBV暴露占主导,几乎所有儿童在5岁时就被感染。在苏莱曼尼亚,刚过50%的儿童在3岁时EBV血清呈阳性,15岁时血清阳性率达到90%。在欧洲和北美,血清阳性通常推迟到青春期或青年期,成人BL多于儿童BL。
在中东地区,儿童BL相对常见,成人BL罕见。在苏莱曼尼亚,EBV血清阳性率在整个儿童期逐渐上升,在青春期中期达到92%。这可能更广泛地反映了中东地区的情况。我们认为,儿童BL发病率高而成人BL发病率低可能是EBV暴露模式介于幼儿期与青少年及青年期感染之间的一种区域效应。